Benjamina Esapa
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond.
Journal: Physiological reviews
Published: March 19, 2026
An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer.
Journal: NPJ precision oncology
Published: August 31, 2025
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.
Journal: Cancer research
Published: August 30, 2024
Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 12, 2023
Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers.
Journal: Cancers
Published: February 09, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026